Novartis and The Max Foundation Transform Pioneering Cancer Access Program for People in Lower-Income Countries
The Max Foundation to lead program for patients and oversee supply chain management; Novartis to contribute funding and product donation.
Novartis Foundation and its partners, including Intel Corporation, the NCD Alliance, city governments and local partners, announce the launch of Better Hearts Better Cities.
Leaders from Novartis, Sodexo, Johnson & Johnson and Marriott International provide insights into critical factors that enabled their companies to make progress in gender balance in senior leadership.
"We have much to gain from Dr. Narasimhan's leadership in both global health and in drug development at Novartis," said Head of the Novartis Foundation Ann Aerts.
Novartis enters into an exclusive option agreement with Ionis and Akcea to license two investigational treatments expected to reduce cardiovascular risk in patients living with elevated levels of lipoprotein.
Novartis Acquires Selexys Pharmaceuticals Corporation, SelG1 Antibody for Pain Reduction in Sickle Cell Disease
Acquisition complements and broadens Novartis' hematology pipeline and underscores commitment to improving care for patients with high unmet needs.
DIVERSITYINC TOP 50
© Copyright 2018 — DiversityInc All Rights Reserved.